Weizmannia coagulans NCU-33 improves rheumatoid arthritis through anti-inflammatory and immunomodulatory effects
The limitations of current rheumatoid arthritis (RA) therapies, including substantial adverse effects and economic burden, necessitate the development of safer, cost-effective adjunct treatments. Probiotic-based interventions targeting the gut-joint axis hold therapeutic promise, yet their precise mechanisms of act...